A Randomized, Parallel-Group Study on the Duration Response of Highly Concentrated On Label Dose (COLD) of BOTOX® Compared to the On Label Dose and Concentration (OLD) in Subjects With Moderate to Severe Dynamic Glabellar Lines
Latest Information Update: 05 Oct 2023
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Glabellar lines
- Focus Therapeutic Use
Most Recent Events
- 22 Oct 2021 New trial record
- 20 Oct 2021 Status changed from not yet recruiting to recruiting.